Grifols' Biotest Gets FDA Approval for Yimmugo-March 2024-www.financetom.com

Grifols' Biotest Gets FDA Approval for Yimmugo

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Grifols' Biotest Gets FDA Approval for Yimmugo

Jun 17, 2024 6:03 AM

08:41 AM EDT, 06/17/2024 (MT Newswires) -- Grifols ( GRFS ) said Monday its subsidiary Biotest received approval from the US Food and Drug Administration for Yimmugo, an antibody injection, to treat primary immunodeficiencies.

Yimmugo is Biotest's first US-approved medicine and was developed using the company's new "Next Level" production facility, Grifols ( GRFS ) said.

Price: 7.07, Change: +0.07, Percent Change: +1.00

Previous page： --Realty Income to Pay Monthly Dividend of $0.2635 a Share, Payable Nov. 15 to Shareholders of Record Nov. 1 Next page： US FAA could approve SpaceX Starship 5 license this month, says source

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

--Realty Income to Pay Monthly Dividend of $0.2635 a Share, Payable Nov. 15 to Shareholders of Record Nov. 1

Oct 10, 2024

04:13 PM EDT, 10/08/2024 (MT Newswires) -- Price: 61.51, Change: -0.01, Percent Change: -0.02 ...

US FAA could approve SpaceX Starship 5 license this month, says source

Oct 10, 2024

WASHINGTON (Reuters) - The Federal Aviation Administration could approve a license for the launch of SpaceX's Starship 5 as soon as this month, a source told Reuters on Tuesday. Last month, the FAA said it did not expect a determination on a license before late November. SpaceX said on social media late on Monday that Starship's fifth flight test could...

Crinetics Pharmaceuticals Plans $400 Million Stock Sale

Oct 10, 2024

04:14 PM EDT, 10/08/2024 (MT Newswires) -- Crinetics Pharmaceuticals ( CRNX ) turned more than 3% lower in Tuesday's extended session after disclosing plans for a $400 million public offering of its common stock, subject to market and other conditions. The clinical-stage pharmaceutical company also would provide underwriters with a 30-day option to buy up to $60 million additional shares...

Lufthansa's risky Italy bet hinges on Rome airport expansion

Oct 10, 2024

ROME/LONDON/FRANKFURT (Reuters) - Lufthansa's long-promised turnaround of Italy's ITA Airways, crucial to help revive the German airline's fortunes, is interlinked with Rome airport Fiumicino's ability to implement an ambitious expansion plan. Struggling with high costs and prolonged delays in Boeing plane deliveries, Lufthansa CEO Carsten Spohr said on Oct. 1 that investing in further international growth - which includes the...